Open Access 27.10.2020 | Correction
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
Erschienen in: Targeted Oncology | Ausgabe 6/2020
Open Access 27.10.2020 | Correction
Erschienen in: Targeted Oncology | Ausgabe 6/2020